Yale Researchers Find Arthritis Drug That Reverses Hair Loss From Alopecia
There is currently no cure for alopecia universalis, a condition that causes those who suffer from it to lose all of the hair on their bodies. But scientists at Yale University recently had huge success treating the condition using the rheumatoid arthritis drug tofacitinib – marketed by Pfizer as Xeljanz.
Dr. Brett A. King and his team of researchers recently tested the drug out on a man with alopecia. They administered him a 10mg dose twice daily for two months followed by a 15mg dose twice daily for another three months. By the end of the trial, the patient experienced incredible results and re-grew hair over his entire body.
“The results are exactly what we hoped for,” Dr. King said. “This is a huge step forward in the treatment of patients with this condition. While it's one case, we anticipated the successful treatment of this man based on our current understanding of the disease and the drug. We believe the same results will be duplicated in other patients, and we plan to try."
Scientists believe the drug worked by getting the patient’s immune system to stop attacking his hair follicles.
“By eight months there was full regrowth of hair,” study co-author Brittany G. Craiglow, M.D. said. “The patient has reported feeling no side effects, and we've seen no lab test abnormalities, either.”
Want to see the patient’s incredible progress? Take a look at these pictures: